MARLBOROUGH, Mass. BERLIN, Germany and YOKNEAM ILIT, Israel, Oct. 31, 2022 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq:RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its third quarter 2022 financial results on Monday, November 7, 2022, at 8:30 AM Eastern time.
Larry Jasinski, Chief Executive Officer, and Michael Lawless, Chief Financial Officer, will host a conference call to discuss the results as follows:
| Time | 8:30 A.M EST |
| Toll free (U.S.) | 1-833-630-1956 |
| International (U.S) | 1-412-317-1837 |
| Germany | 0800-6647650 |
| Israel | 1-80-9212373 |
| Access Code | Please request to be connected to ReWalk Robotics Ltd. call |
| Webcast (live and replay) | https://edge.media-server.com/mmc/p/guz9jm9p under the ‘Investors’ section’. |
The archived webcast will be available via the following link https://edge.media-server.com/mmc/p/guz9jm9p or through the ‘Investors’ section’ on www.rewalk.com.
About ReWalk Robotics Ltd.
ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke. ReWalk’s mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany. For more information on the ReWalk systems, please visit www.rewalk.com.
ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel and the Unites States.
Investor Contact:
Michael Lawless
Chief Financial Officer
ReWalk Robotics Ltd.
T: +1 508-281-7274
E: investorrelations@rewalk.com
Related news for (RWLK)
- ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward
- Sidoti Events, LLC’s Virtual January Micro-Cap Conference
- ReWalk Robotics Reports First Quarter 2023 Financial Results
- Advancement in ReWalk Technology Achieves FDA Clearance as Only Personal Exoskeleton to Enable Use on Stairs and Curbs
- Germany’s second largest health insurer withdraws appeal with Federal Social Court, accepts prior ruling of exoskeletons as direct disability compensation